ID   CPA-Yang3
AC   CVCL_L787
DR   Wikidata; Q54814379
RX   Patent=CN101955911B;
RX   PubMed=21342638;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.3137.
CC   Population: Chinese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
RX   Patent=CN101955911B;
RA   Yang S.-F.;
RT   "Chinese lung adenocarcinoma cell line with high metastases
RT   potentiality of bone, liver and adrenal gland.";
RL   Patent number CN101955911B, 23-May-2012.
//
RX   PubMed=21342638; DOI=10.3779/j.issn.1009-3419.2011.02.01;
RA   Yang S.-F., Shi M.-P., Cao J., Su J.-Z., Zhao L.-X., Lei B., Chang C.,
RA   Lu J.-Y., Ye J.-D., Xie W.-H.;
RT   "Establishment of a novel Chinese human lung adenocarcinoma cell line
RT   CPA-Yang3 and its real bone metastasis clone CPA-Yang3BM in
RT   immunodeficient mice.";
RL   Zhongguo Fei Ai Za Zhi 14:79-85(2011).
//